Table 6.
Association of Adipose Tissue Volumes With Abdominal Aortic Dimensions in Subset of Individuals with Adipokines
| Age- and Sex- and RF Adjusted* | +BMI† | +Adipokines† | ||||
|---|---|---|---|---|---|---|
| β (95% CI) | P | β (95% CI) | P | β (95% CI) | P | |
| TAT | 0.33 (0.18 to 0.47) | <0.001 | 0.12 (−0.04 to 0.28) | 0.15 | 0.13 (−0.03 to 0.29) | 0.11 |
| VAT | 0.27 (0.13 to 0.40) | <0.001 | −0.05 (0.22 to 0.12) | 0.56 | −0.03 (−0.20 to 0.14) | 0.71 |
| Secondary Analysis | ||||||
| AAT | 0.25 (0.11 to 0.39) | <0.001 | 0.06 (−0.09 to 0.21) | 0.45 | 0.07 (−0.08 to 0.22) | 0.39 |
BMI indicates body mass index; TAT, thoracic periaortic adipose tissue volume; VAT, visceral adipose tissue volume; and AAT, abdominal periaortic adipose tissue volume.
*
Adjusted for the following covariates: age, sex, smoking (current, former or never), systolic blood pressure, blood pressure treatment, total cholesterol/HDL ratio, lipid treatment, diabetes). All β coefficients presented are per 1 standard deviation change in fat volume.
†
For +BMI and +adipokines, BMI and adipokines were added serially in nested models (first BMI was added to the baseline model, then log [adiponectin] and log [resistin] were added).